Cargando…
Oncogenic HBXIP enhances ZEB1 through Sp1 to accelerate breast cancer growth
BACKGROUND: There is abundant evidence to indicate that HBXIP functions as an oncoprotein and transcription co‐activator during the development and promotion of cancers. In multiple cancers, ZEB1 serves as a transcription activator to regulate gene expression. We explored the roles of ZEB1 in HBXIP‐...
Autores principales: | Jiang, Yang, Wang, Dan, Ren, Hui, Shi, Ying, Gao, Yufei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275833/ https://www.ncbi.nlm.nih.gov/pubmed/30273966 http://dx.doi.org/10.1111/1759-7714.12878 |
Ejemplares similares
-
MiR‐145‐targeted HBXIP modulates human breast cancer cell proliferation
por: Jiang, Yang, et al.
Publicado: (2018) -
The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells
por: Yue, Lin, et al.
Publicado: (2013) -
Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
por: Wu, Hua-Tao, et al.
Publicado: (2020) -
Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP
por: Zhang, Weiying, et al.
Publicado: (2014) -
The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer
por: Liu, Fabao, et al.
Publicado: (2015)